BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2020
View Archived Issues
Brown fat activity without fat browning
Read More
FDA lifts hold and clears IND application for IMS-001
Read More
Agonists selectively wake up melatonin receptor subtypes
Read More
IND application for AG-946 cleared by FDA
Read More
Enhancing TREM2's protective function on microglia as a novel approach for Alzheimer's disease
Read More
Ciclesonide shows antiviral activity against SARS-CoV-2
Read More
First patients enrolled in RECOVERY study evaluating potential COVID-19 treatments
Read More
Vaccitech presents initial data from phase IIa ADVANCE study of VTP-800
Read More
miR-423-5p and miR-128-3p in serum exosome as biomarkers for testicular injury
Read More
Novel lipid biomarkers for ETH-induced hepatic steatosis
Read More
Elevated AXIN1 expression as predictor of PTSD development
Read More
TNFSF14 is a therapeutic target in eosinophilic esophagitis
Read More
Biomarkers predict renal recovery from acute kidney injury requiring dialysis
Read More
Nanocells deliver cytotoxin, activate immune system
Read More
Roche and Genentech patent TEAD inhibitors
Read More
Novartis divulges new compounds for herpesvirus infection
Read More
H. Lee Moffitt Cancer Center and Research Institute presents BRD4-JAK2 inhibitors
Read More
Otsuka Pharmaceutical identifies AhR antagonists
Read More
New AMPK activators presented by Skylark Bioscience
Read More
Ascletis publishes data from clinical study of danoprevir for COVID-19
Read More
Novartis' Beovu approved in Japan for neovascular age-related macular degeneration
Read More
Japanese approval of Tepmetko for advanced NSCLC with METex14 skipping alterations
Read More
Phase I results with losmapimod for FSHD show target engagement in muscle
Read More
Antolimab begins new trials, shows promise for mast cell gastrointestinal disease
Read More
BeiGene studies BGB-11417 in phase I for mature B-cell malignancies
Read More
